ea0014p35 | (1) | ECE2007
Kemal Yasemin
, Demirag Nilgun
, Tutuncu Neslihan
, Yildirir Aylin
, Atar Asli
, Unal Asli
Objective: Thiazolidinediones (TZDs) have become a powerful tool for lowering insulin resistance. The problem of cardiovascular adverse events including fluid retention and risk of heart failure, although of a low incidence, should be well known and recognized. We aimed to evaluate the effects of rosiglitazone treatment on cardiac function and show whether these effects are reversible when we continued this treatment.Methods: Fourty-six type 2 diabetic p...